Selected outcome
Before 2032
73%
Before 2032 · 73%
Stored quote · checking the venue
- Scheduled end
- Dec 31, 2029 ET
- Resolution source
- Food and Drug Administration (opens in a new tab)
Price
Loading price history.
Markets
- Before 2030
Will the FDA approve VERVE-102 before Jan 1, 2030?
54%
Open · ~$0 24h · ~$697 vol
Bid 51¢ · Ask 57¢
- Before 2031
Will the FDA approve VERVE-102 before Jan 1, 2031?
66%
Open · ~$0 24h · ~$81 vol
Bid 62¢ · Ask 69¢
- Before 2032
Will the FDA approve VERVE-102 before Jan 1, 2032?
73%
Open · ~$0 24h · ~$27 vol
Bid 69¢ · Ask 76¢
- Before 2033
Will the FDA approve VERVE-102 before Jan 1, 2033?
76%
Open · ~$0 24h · ~$2 vol
Bid 72¢ · Ask 79¢
- Before 2034
Will the FDA approve VERVE-102 before Jan 1, 2034?
79%
Open · ~$0 24h · ~$39 vol
Bid 77¢ · Ask 81¢
- Before 2035
Will the FDA approve VERVE-102 before Jan 1, 2035?
84%
Open · ~$0 24h · ~$289 vol
Bid 80¢ · Ask 87¢
Event statistics
How this resolves
- Scheduled end
- Dec 31, 2029 ET
- Resolution source
- Trading
- Closed
- In review
- Resolved
Rules text
If the FDA approves VERVE-102 for marketing before Jan 1, 2032, then the market resolves to Yes.